Results · Apr-Jun 2026
Natraj Proteins Q1 FY27 results
Sales grew 18% to ₹31.4 crore from ₹26.6 crore in Apr-Jun 2025.
Operating profit was ₹2.8 crore, an operating margin of 8.9% (up 11.3 points from a year ago).
Net profit turned positive: ₹2.1 crore against a loss of ₹1.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +66%, net profit +90%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 31.4 | 26.6 | +18% |
| Operating profit (EBITDA) | 2.8 | -0.6 | n/m |
| Operating margin | 8.9% | −2.4% | +11.3 pts |
| Net profit | 2.1 | -1.2 | turns positive |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.